KOD · Kodiak Sciences Inc.
$41.15
+1.14 (+2.84%)
At close · Jul 30
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our financial condition raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$2.50B
Shares
62.58M
Kodiak Sciences Inc. Earnings Call Transcripts
Every quarterly earnings call for Kodiak Sciences Inc. (KOD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY25 · Q3
2025-11-13
Kodiak Sciences Inc. Q3 FY2025 Earnings Call
Diluted EPS
$-1.16
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Kodiak Sciences Inc. Q2 FY2025 Earnings Call
Diluted EPS
$-1.03
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
Kodiak Sciences Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Kodiak Sciences Inc. Q3 FY2024 Earnings Call
Diluted EPS
$-0.84
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-28
Kodiak Sciences Inc. Q4 FY2023 Earnings Call
Positive tone
Tarcocimab Phase 3 program and GLOW2 / DAYBREAK
KSI-501 enhanced formulation and wet AMD pivotal
Uncertainty around second KSI-501 pivotal study timing
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q1
2020-05-11
Kodiak Sciences Inc. Q1 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–6 of 6 earnings calls